Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 2:32:100539.
doi: 10.1016/j.pacs.2023.100539. eCollection 2023 Aug.

A review of a strategic roadmapping exercise to advance clinical translation of photoacoustic imaging: From current barriers to future adoption

Affiliations
Review

A review of a strategic roadmapping exercise to advance clinical translation of photoacoustic imaging: From current barriers to future adoption

Hisham Assi et al. Photoacoustics. .

Abstract

Photoacoustic imaging (PAI), also referred to as optoacoustic imaging, has shown promise in early-stage clinical trials in a range of applications from inflammatory diseases to cancer. While the first PAI systems have recently received regulatory approvals, successful adoption of PAI technology into healthcare systems for clinical decision making must still overcome a range of barriers, from education and training to data acquisition and interpretation. The International Photoacoustic Standardisation Consortium (IPASC) undertook an community exercise in 2022 to identify and understand these barriers, then develop a roadmap of strategic plans to address them. Here, we outline the nature and scope of the barriers that were identified, along with short-, medium- and long-term community efforts required to overcome them, both within and beyond the IPASC group.

Keywords: Clinical translation; Optoacoustic tomography; Phantoms; Photoacoustic imaging; Quality assurance; Standardisation.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The promotions and salary of Kurinchi Gurusamy are dependent upon journal publications. Ferdinand Knieling is co-inventor with iThera Medical GmbH, Germany on an EU patent (EP 19 163 304.9) relating to a device and a method for analysing optoacoustic data, an optoacoustic system and a computer program. He received travel support by iThera Medical GmbH, Germany, lecture fees from Sanofi Genzyme and Siemens Healthcare GmbH outside the submitted work. Given his role as Section Editor of this journal, Ferdinand Knieling had no involvement in the peer-review of articles for which he was an author and had no access to information regarding their peer-review. AAO is an employee and stock holder of TomoWave and Seno Medical, which develop and sell optoacoustic tomography systems. Given his role as the Editor in Chief of this Journal, AAO had no involvement in the peer-review process or the decisions regarding acceptance of manuscripts for which he is an author. Given her role as an Editorial Board member of this journal, Sarah Bohndiek had no involvement in the peer-review of articles for which she was an author and had no access to information regarding their peer-review. Full responsibility for the peer-review process for this article was delegated to another Editor. Martin Leahy is the inventor of WIPO patent (WO2015110349A1) relating to photoacoustic tomography method and system which uses known intrinsic absorbers for fluence correction. Lihong Wang has a financial interest in Microphotoacoustics, Inc., CalPACT, LLC, and Union Photoacoustic Technologies, Ltd., which, however, did not support this work. Ledia Lilaj is an employee of iThera Medical GmbH, a vendor of optoacoustic imaging instruments. Mithun Kuniyil Ajith Singh is an employee of CYBERDYNE Inc, a vendor of photoacoustic imaging instruments. The other authors do not declare any conflicts of interest.

Figures

Fig. 1
Fig. 1
Mapping the barriers identified, separated horizontally, onto their position in the clinical translational pipeline, shown in the vertical direction. The translational pipeline is divided according to phases of discovery, validation and qualification, as defined previously . Each of the thematic groupings of barriers (left to right: clinical adoption, standards development, test objects and methods, and data management) are explained in more detail in the text and form the basis of the output roadmaps.
Fig. 2
Fig. 2
Roadmap for clinical adoption activities. OEM = original equipment manufacturer.
Fig. 3
Fig. 3
Roadmap for standards activities.
Fig. 4
Fig. 4
Roadmap for the development of stable test objects and methods. SOP=Standard operating procedure.
Fig. 5
Fig. 5
Roadmap for the development of a comprehensive PA database that can function as a validation framework and aid in the understanding of technical and methodological limitations.
Fig. 6
Fig. 6
Summary of the goals of IPASC emerging from the roadmapping workshop.

References

    1. Wang, L. v & Hu, S. Photoacoustic Tomography: In Vivo Imaging from Organelles to Organs. 〈https://www.science.org〉. - PMC - PubMed
    1. Oraevsky A.A., Karabutov A.A. In: Biomedical Photonics Handbook. Vo-Dinh T., editor. CRC Press; 2003. Optoacoustic tomography.
    1. Lemaster J.E., Jokerst J. v. What is new in nanoparticle-based photoacoustic imaging? Wiley Interdiscip. Rev.: Nanomed. Nanobiotechnology. 2017;9 doi: 10.1002/wnan.1404. - DOI - PMC - PubMed
    1. Weber J., Beard P.C., Bohndiek S.E. Contrast agents for molecular photoacoustic imaging. Nat. Methods. 2016;13:639–650. doi: 10.1038/nmeth.3929. - DOI - PubMed
    1. Zhang Y., Olick-Gibson J., Khadria A., Wang L.V. Photoacoustic vector tomography for deep hemodynamic imaging. Nat. Biomed. Eng. Press. 2023 - PMC - PubMed